Cargando…

Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a major cause for long-term disability, yet the treatments available that improve outcomes after TBI limited. Neuroinflammatory responses are key contributors to determining patient outcomes after TBI. Transplantation of mesenchymal stem cells (MSCs), whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peruzzaro, S. T., Andrews, M. M. M., Al-Gharaibeh, A., Pupiec, O., Resk, M., Story, D., Maiti, P., Rossignol, J., Dunbar, G. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320578/ https://www.ncbi.nlm.nih.gov/pubmed/30611291 http://dx.doi.org/10.1186/s12974-018-1383-2

Ejemplares similares

Correction to: Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury
por: Peruzzaro, S. T., et al.
Publicado: (2022)

Transplantation of mesenchymal stem cells overexpressing interleukin‐10 induces autophagy response and promotes neuroprotection in a rat model of TBI
por: Maiti, Panchanan, et al.
Publicado: (2019)

Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington’s Disease
por: Gharaibeh, Abeer, et al.
Publicado: (2020)

Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease
por: Al-Gharaibeh, Abeer, et al.
Publicado: (2017)

Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke
por: Nakajima, Masataka, et al.
Publicado: (2017)

PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
por: Srinageshwar, Bhairavi, et al.
Publicado: (2017)

Overexpression of interleukin‐10 in engineered macrophages protects endothelial cells against LPS‐induced injury in vitro
por: Yi, Lingxian, et al.
Publicado: (2022)

Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
por: Paladugu, Leela, et al.
Publicado: (2021)

A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin
por: Maiti, Panchanan, et al.
Publicado: (2017)

Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases
por: Srinageshwar, Bhairavi, et al.
Publicado: (2016)

Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells
por: Maiti, Panchanan, et al.
Publicado: (2019)

Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice
por: Meng, Xin, et al.
Publicado: (2019)

Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
por: Wyse, Robert D., et al.
Publicado: (2014)

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017)

Metabolic engineering of apple by overexpression of the MdMyb10 gene
por: Rihani, Khaled A.L., et al.
Publicado: (2017)

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease
por: Dunbar, Gary L., et al.
Publicado: (2019)

The Generation of an Engineered Interleukin-10 Protein With Improved Stability and Biological Function
por: Minshawi, Faisal, et al.
Publicado: (2020)

Interleukin-10 Overexpression Promotes Fas-Ligand-Dependent Chronic Macrophage-Mediated Demyelinating Polyneuropathy
por: Dace, Dru S., et al.
Publicado: (2009)

Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits, Gliosis, and Amyloid-Beta Deposition in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Bowers, Zackary, et al.
Publicado: (2021)

Correction: Bowers et al. Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits and Gliosis in the 5xFAD Mouse Model of Alzheimer’s Disease. Brain Sci. 2021, 11, 1423
por: Bowers, Zackary, et al.
Publicado: (2023)

Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells
por: Enam, Syed Faaiz, et al.
Publicado: (2020)

Mesenchymal Stem Cells Decrease Oxidative Stress in the Bowels of Interleukin-10 Knockout Mice
por: Jung, Kyong Jin, et al.
Publicado: (2020)

Strain-engineered MOSFETs
por: Maiti, CK, et al.
Publicado: (2012)

Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis
por: Fink, Kyle D, et al.
Publicado: (2013)

Amniotic-Fluid–Derived Mesenchymal Stem Cells Overexpressing Interleukin-1 Receptor Antagonist Improve Fulminant Hepatic Failure
por: Zheng, Yu-Bao, et al.
Publicado: (2012)

Regulation of the Anti-Inflammatory Cytokines Interleukin-4 and Interleukin-10 during Pregnancy
por: Chatterjee, Piyali, et al.
Publicado: (2014)

Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury
por: Lagerstedt, Linnéa, et al.
Publicado: (2018)

Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer
por: Fujita, Takeo, et al.
Publicado: (2009)

Overexpression of Interleukin-23 and Interleukin-17 in the Lesion of Pemphigus Vulgaris: A Preliminary Study
por: Xue, Jixin, et al.
Publicado: (2014)

IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10
por: Steen‐Louws, C., et al.
Publicado: (2018)

Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP
por: Dang, Yunzhi, et al.
Publicado: (2020)

Glycosylation-Engineered Platelet Membrane-Coated Interleukin 10 Nanoparticles for Targeted Inhibition of Vascular Restenosis
por: Li, Fengshi, et al.
Publicado: (2023)

Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages
por: Gao, Tianyun, et al.
Publicado: (2022)

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer
por: Zeng, Jun, et al.
Publicado: (2017)

Successful Use of mRNA-Nucleofection for Overexpression of Interleukin-10 in Murine Monocytes/Macrophages for Anti-inflammatory Therapy in a Murine Model of Autoimmune Myocarditis
por: Zimmermann, Oliver, et al.
Publicado: (2012)

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
por: Chang, Chun-Chun, et al.
Publicado: (2020)

Serum Levels of Interleukin 10 (IL-10) in Patients with Type 2 Diabetes
por: Yaghini, N, et al.
Publicado: (2011)

Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury
por: Thome, Jason G., et al.
Publicado: (2020)

Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9mpogt6qk00gek9eddtde9bb2m